CarlssonBLundbergCOhlssonK.Granulocyte proteases in middle ear effusions. Ann Otol Rhinol Laryngol1982;91:76–81.
2.
HamaguchiYSakakuraKMajimaYSakakuraYMiyoshiY.Lysosomal proteases (cathepsin B-like proteases) in serous MEEs from adult patients. Acta Otolaryngol (Stockh)1986;101:257–62.
3.
HamaguchiYSakakuraKMajimaYSakakuraY.Lysosomal thiol proteases in middle ear effusions. Ann Otol Rhinol Laryngol1986;95(Suppl 124):9–12.
4.
JuhnSKPaparellaMMKimCSGoycooleaMVGiebinkGS. Pathogenesis of otitis media. Ann Otol Rhinol Laryngol1977; 86:481–92.
5.
HamaguchiYJuhnSKSakakuraY.Protease inhibitors in middle ear effusions from experimental otitis media with effusion. Ann Otol Rhinol Laryngol1988 (in press).
6.
NagasawaSSugiharaHHanBHSuzukiT.Studies of α2-macroglobulin in bovine plasma. J Biochem (Tokyo)1970;67:809–18.
7.
ErikssonS.Proteases and protease inhibitors in chronic obstructive lung disease. Acta Med Scand1978;203:449–55.
8.
BarrettAJStarkeyPM. The interaction of α2-macroglobulin with proteinases. Biochem J1973;133:709–24.
9.
HamaguchiYOhiMUkaiKSakakuraYMiyoshiY.Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions. Ann Otol Rhinol Laryngol1985;94:293–6.
10.
JuhnSKSipiläPJungTTKEdlinJ.Biochemical pathology of otitis media with effusion. Acta Otolaryngol [Suppl] (Stockh)1984 (suppl 414):45–51.
11.
ZaslowMCClarkRAStonePJCaloreJDSniderGLFranzblauC.Human neutrophil elastase does not bind to α1-protease inhibitor that has not been exposed to activated human neutrophils. Am Rev Respir Dis1983;128:434–9.
12.
OhlssonK.Elimination of 125I-trypsin-α2-macroglobulin complexes from blood by reticuloendothelial cells in dog. Acta Physiol Scand1971;81:269–72.
13.
JungTTKSheaDGiebinkGSJuhnSK. Histopathology of animal models of otitis media in chinchillas. Ann Otol Rhinol Laryngol1985;94(Suppl 120): 13–4.
